scientific Sessions

COVID 19 Virology and Vaccines

The virus under study for COVID-19 virology is SARS-CoV-2, an RNA virus with the spike protein attaching to human cells through the ACE2 receptor. It brings about respiratory manifestations of mild to severe intensity and even pneumonia or death in susceptible persons. In combating the pandemic, various vaccine technologies were developed; these include mRNA vaccines from Pfizer-BioNTech and Moderna, as well as the viral vector vaccine from AstraZeneca and Johnson & Johnson, and lastly, the protein subunit vaccine from Novavax. These vaccines have decreased severe illness and death. Current research is still being done on boosters, variants, and long-term immunity, with the World Vaccines R&D Conference bringing the world together to accelerate vaccine development.

Related Sessions

Vaccinology
Vaccine Design and Development
Vaccine Delivery Systems
Infectious Diseases and Vaccines
Generations of Vaccines
Cancer Treatment Vaccines
Advances in Vaccines
Post marketing Surveillance
Veterinary Vaccines
Reverse Vaccinology
Vaccine Equity
Detecting Viruses
Viral Replication
Viral Sequencing
COVID 19 Virology and Vaccines
Viral Infection Symptoms
Plant and Animal Viruses
Bacterial and Archaeal Viruses
Clinical Trials in Vaccines
Viruses in Research and Medicine
Virus Nanotechnology
Systems Vaccinology
Vaccines against STIs
Vaccine Formulation
Vaccine Production Technology
Vaccine Durability
Immunization of Special Risk Groups
Models for Vaccine Evaluation
Advancement in Vaccine Design for Broad Protection
Vaccine Immunology
Don't miss our future updates!

Get in Touch